Conferences
4–8 September 2012, Oxford, UK
DrugDesign2012: Structure-Based Drug Design
DrugDesign 2012 - Oxford’s first drug design conference - will address the latest developments in computational and experimental approaches to ligand- and structure-based drug design. This conference is aimed at bringing together scientists from academia and industry to stimulate and step up the development of cutting-edge in silico and experimental drug design approaches. The conference invites podium and poster proposals in the following general areas of drug design:-
Molecular modelling and simulation Novel drugable targets: Identification and selection Fragment binding and selectivity Structure-based inhibitor design Ligand design and identification Target-ligand interaction (including proteins and nucleic acids) In silico and experimental screening technologies.